New Enterprise Associates

Chaos Industries is a technology company focused on defense and critical industries, developing advanced sensing, detection, and communication capabilities. It leverages Coherent Distributed Networks to enhance sensing, detection, and communication across platforms and emphasizes time synchronization to enable highly mobile, scalable, and cost-efficient systems. The company delivers integrated, software-defined solutions for defense, government, and industrial applications in challenging environments.

Veza is the data security platform that helps users use and share their data safely. It makes it easy to understand, manage, and control who can and should take what action on what data. It organizes authorization metadata across identity providers, data systems, cloud service providers, and applications, all to address the toughest data security challenges of the modern era. The company is funded by top-tier investors including Accel, Bain Capital, Ballistic Ventures, Blackstone, GV, Norwest Venture Partners, and True Ventures.

Glacier develops AI-enabled recycling robots for recycling facilities. Founded in 2019 and headquartered in San Francisco, California, the company creates affordable, high-performing, and space-efficient robots that automate the sorting of recyclable materials. Its platform combines artificial intelligence-powered sensors and robotics to streamline operations, improve sorting accuracy, and increase profitability for waste facilities.

Plaid is a technology platform that provides APIs and developer tools to connect consumer bank accounts and financial data with applications. It enables developers to build modern financial services by offering infrastructure and intelligence tools that allow access to transactions, authentication for bank accounts, identity verification, real-time balances, asset verification, and income data. Its products include Transactions, Auth, Identity, Balance, Assets, and Income, supporting personal finance, consumer payments, lending, banking and brokerage, and business finance solutions. Plaid serves developers from startups to large financial institutions, helping democratize financial services with a developer-friendly experience. The company was founded in 2012 and is headquartered in San Francisco, California.

Aetherflux is an aerospace company focused on providing renewable energy solutions to households, businesses, and military operations worldwide. The company has developed an innovative design for space-based solar power, which entails a constellation of small satellites that harness sunlight, convert it into electricity, and wirelessly transmit the power to ground stations. This technology aims to deliver reliable energy distribution while minimizing environmental impact, positioning Aetherflux at the forefront of the renewable energy sector.

Vori Health offers an integrated medical practice specializing in treating musculoskeletal conditions. Its nationwide, evidence-based approach addresses back, neck, and joint issues through a unique, virtual-first care model. Patients are connected to a collaborative team consisting of a board-certified physician, health coach navigator, and physical therapist for comprehensive care.

Ceramic.ai builds enterprise-grade infrastructure to optimize how companies train and deploy their AI models

Ceramic is an AI company that specializes in streamlining the process of training artificial intelligence models for businesses. Their platform optimizes data processing and supports long-context training across various cluster sizes, making AI model training faster and more cost-effective. This enables enterprises to efficiently build and fine-tune their own generative AI models.

Metronome provides billing infrastructure for software companies, facilitating rapid deployment, flexibility, and user-friendly solutions. It enables business and product teams to manage revenue and pricing independently, streamlining workflows and offering customers real-time spending insights.

Cambium Carbon is an early-stage social enterprise focused on addressing climate change through innovative reforestation and urban wood reuse initiatives. The company collaborates with cities and various public and private partners to salvage fallen city trees that would otherwise end up in landfills. By transforming this wood waste into valuable resources, Cambium Carbon establishes reforestation hubs that create a circular economy for urban forests. These hubs not only generate revenue to support tree planting and maintenance projects but also foster sustainable job creation and contribute to the development of resilient urban environments. Through its efforts, Cambium Carbon aims to implement systems-level natural climate solutions that benefit both the environment and local communities.

Abcuro develops immunotherapies targeting autoimmunity and cancer. Founded in 2015, the company uses bioinformatics and ex-vivo validation to uncover novel immune system targets.

Music AI is a software company specializing in artificial intelligence solutions for music and audio technology. It offers musicians and producers a suite of AI tools including audio separation, pitch/chord detection, metronome, tempo changer, and mastering.

Instabase, Inc. is a technology company based in San Francisco, California, founded in 2015. It specializes in developing a platform that automates document processing workflows and analyzes unstructured data. The platform integrates various capabilities, including optical character recognition, data classification and extraction, and natural language processing, allowing organizations across sectors such as insurance, finance, and healthcare to streamline operations and improve decision-making. Additionally, Instabase provides a developer kit that enables the creation of customized business applications, helping institutions embed artificial intelligence into their systems and processes. Through its innovative solutions, Instabase aims to address significant business challenges and facilitate transformational outcomes for its clients.

Founded in London in 2017, Synthesia Ltd. specializes in AI-driven video generation platforms. Its technology transforms text into professional videos with customizable avatars and voiceovers in over 140 languages, enabling efficient creation of personalized advertising, corporate communications, e-learning content, and more.

Tune Therapeutics is a biotechnology company focused on developing innovative cell and gene therapies. It employs an epigenetic programming platform to create novel therapeutic pathways, aiming to treat severe diseases without modifying the underlying DNA sequence.

Ouroboros Medicines is a biotechnology company dedicated to immunology, focusing on treating chronic immune-mediated illnesses. It specializes in developing immune reset treatments, using a therapeutic platform that employs T cell engager antibodies to target and deplete specific pathogenic cells. This approach aims to provide extended remissions for patients, without the need for ongoing immunosuppression. The company's strength lies in its integration of scientific knowledge and proven track record in progressing cell-depleting treatments through clinical trials, supported by a robust pipeline.

FIRE1 is an Irish-based company specializing in the development of innovative therapeutic devices. Its flagship product is a remote monitoring system designed to enhance heart failure patients' lives by providing real-time data to healthcare providers, facilitating early detection and proactive interventions.

Orbis Medicines is a company that develops a macrocyclic chemistry and computational platform for oral macrocycle drug discovery. The platform generates macrocycle candidates, nCycles, optimized for oral bioavailability to advance therapeutics that historically faced development hurdles. Its pipeline centers on nCycle candidates targeting validated biologic targets that are typically addressed by injectable drugs, with the goal of enabling oral delivery of such therapies. The platform combines chemistry and computational methods to accelerate drug discovery toward challenging targets in unmet-need indications, supporting therapeutics designed to improve patient outcomes.

NeueHealth is a healthcare company dedicated to providing high-quality, coordinated care to aging and underserved populations. It operates through two segments: NeueCare, which manages risk in partnership with external payors, serving diverse patient populations; and NeueSolutions, offering technology, services, and clinical care solutions to empower providers.

Courtyard is a platform facilitating secure ownership transfer of physical collectibles worldwide via non-fungible tokens (NFTs), eliminating the need for physical item movement.

Backflip AI operates a platform that combines human creativity with 3D generative AI, enabling engineers and designers to work efficiently and produce highly realistic models. These models can be used in various applications, such as 3D printing, video game assets, renders, and digital media, as well as in the design of physical structures like buildings and automobiles. The company's technology aims to accelerate design processes and provide businesses with a competitive edge.

Senti Biosciences is a biotechnology company focused on synthetic biology. It develops gene circuit platforms to engineer therapeutics, with a focus on improving precision and control in cancer treatments.

Avenzo Therapeutics focuses on developing innovative cancer treatments. It operates a clinical-stage platform dedicated to creating novel therapies for underserved cancers, with a pipeline targeting rare and genomically defined cancers.

Fastino specializes in developing high-performance, task-optimized language models for enterprise AI developers. Their large language model (LLM) is designed to efficiently and accurately handle a range of data tasks, including structuring, summarization, planning, and sensitive information management. By offering near-instant inference, Fastino helps businesses enhance operational efficiency and process data at scale.

Sana Labs is a leader in applying artificial intelligence to enhance educational outcomes through personalized learning. The company collaborates with prominent organizations to develop its innovative learning platform, which leverages advanced machine learning techniques. This platform is designed to empower education companies and integrates seamlessly with various applications, allowing employees to access knowledge, communicate, and automate tasks effectively. By offering insights into team strengths, weaknesses, and progress, Sana enables institutions in sectors such as healthcare, finance, and pharmaceuticals to improve their workforce's performance and learning experiences. The interdisciplinary team at Sana comprises experts from diverse fields, contributing to its mission of transforming the future of education.

Pathos develops an AI-enabled drug discovery platform aimed at reducing the medication development process. Its self-learning platform uses big data, technology, and artificial intelligence to identify targets, validate them, and establish their clinical efficacy, enabling drug developers to explore novel concepts and advance breakthrough therapies for various diseases.

Outrider develops autonomous electric trucks and management software for logistics hubs. Its technology automates yard operations, enhancing safety and efficiency for large enterprises.

Genmo is a technology company that develops an artificial intelligence platform for creative content generation. Its platform enables users to create high-quality videos, images, and 3D models using intuitive text and image prompts, leveraging advanced natural language processing technology. This allows video creators to generate custom visual media and produce cinematic video content with the assistance of AI.

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies aimed at addressing significant unmet medical needs in fibrosis, lysosomal storage disorders, and oncology. The company has established a robust pipeline supported by a proprietary discovery engine and a wholly-owned research and development facility. It possesses an extensive library of molecules and a team with considerable expertise in developing compounds that target nuclear receptors, transcription factors, and epigenetic modulation. Inventiva is advancing clinical candidates, including lanifibranor, which is being developed for non-alcoholic steatohepatitis (NASH), a condition currently lacking approved treatments. Additionally, the company is engaged in a variety of pre-clinical therapy programs, further strengthening its portfolio in the fields of oncology, fibrosis, and rare diseases.

Firestorm develops modular open-source unmanned aerial platforms and related hardware and software designed for defense applications. The company focuses on open-architecture systems that enable rapid, distributed manufacturing and mission-adaptable configurations. Its platforms feature swappable propulsion and payload options and are supported by mobile micro-factories that enable rapid drone production through advanced additive manufacturing. By enabling customizable, low-cost aerial systems, Firestorm aims to support military and defense operators across varied terrains and missions with adaptable, scalable solutions.

Wispr Flow is a developer of a personal computing platform aimed at an artificial intelligence-first future, emphasizing neural interfaces. The company focuses on a human-centered approach that integrates advancements in neurotechnology, machine learning, and hardware systems. By doing so, Wispr Flow seeks to make cutting-edge technology accessible to a wider audience, allowing users to engage with technology in a more intuitive and natural manner.

858 Therapeutics is a biotechnology company specializing in the discovery of small molecule therapeutics for novel targets in oncology and immunology. The company focuses on innovative approaches such as synthetic lethality, innate immunity, and RNA modulation, with its lead program being a PARG inhibitor currently in early clinical development.

DeltaStream offers a unified self-service platform for stream processing powered by Apache Flink. It enables real-time analytics, efficient scaling, and robust data governance, allowing organizations to harness the power of their streaming data effectively.

World Labs is a technology company that develops an artificial intelligence platform designed for humanlike processing of visual data. Focusing on spatial intelligence, its core service involves the creation of Large World Models (LWMs) that enable AI systems to perceive, generate, and interact with environments in three-dimensional space, both in virtual and real-world contexts. The company's innovative approach incorporates synthetic data to train its models, facilitating advanced computer vision technologies capable of reliably identifying objects. This capability positions World Labs as a key player in the burgeoning fields of augmented and virtual reality.

Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.

Agree.com is the best solution for creating and managing contracts, streamlining negotiations, enhancing compliance, optimizing workflows, and converting more customers — all within one intuitive platform. View edits, track signatures, and get alerted on all upcoming key milestones. Include free, one-click e-signatures with identity verification on every agreement. Increase deal velocity and drive revenue impact with integrated payments.

Sakana AI is a research-focused company dedicated to developing innovative foundation models inspired by nature. It specializes in creating an AI model capable of generating text, images, video, code, and multimedia, facilitating collaborative research and development in generative AI. The company's AI development process emphasizes evolution and collective intelligence.

Ceramic is an AI company that specializes in streamlining the process of training artificial intelligence models for businesses. Their platform optimizes data processing and supports long-context training across various cluster sizes, making AI model training faster and more cost-effective. This enables enterprises to efficiently build and fine-tune their own generative AI models.

PayZen is a healthcare fintech company that helps patients manage out-of-pocket medical expenses by offering flexible, transparent payment plans and non-recourse financing. The platform enables patients to pay bills over time while helping providers accelerate cash flow and reduce costly collections. It uses AI-powered risk assessment to tailor each plan to the individual patient, supporting affordable payments without upfront burden. Founded in 2019 in San Francisco by Ariel Rosenthal, Itzik Cohen, and Tobias Mezger, PayZen aims to reduce financial barriers to care while enabling providers to focus on delivering services.

Moximed develops and provides the Atlas System, an implantable joint unloader designed to alleviate pain and preserve mobility in patients with medial compartment knee osteoarthritis. Its outpatient treatment option aims to improve quality of life for those not responsive to other therapies or candidates for knee replacement.

MBX Biosciences is a biotechnology company focused on developing therapies for endocrine and metabolic disorders, emphasizing rare endocrine diseases with limited treatment options. It pursues discovery, development, and commercialization of first-in-class peptide therapeutics that modulate glandular hormone signaling. MBX has developed a proprietary Precision Endocrine Peptide platform to engineer peptides with extended time-action profiles and consistent drug exposure, aiming to overcome limitations of traditional peptide therapies and improve disease management. Based in Carmel, Indiana, the company advances novel peptide programs through clinical development to address unmet medical needs in endocrine and metabolic disorders.

Augment is a developer of a platform designed for confidential transactions and communications, specifically tailored for the private technology share market. The platform facilitates connections between buyers and sellers by providing an order book within a company's marketplace. Users can identify potential transaction partners, engage in secure communication, and finalize deals, streamlining the process for brokers, investors, and shareholders. This innovative approach allows participants in private market trades to efficiently manage their transactions while maintaining anonymity and confidentiality.

Global Predictions is a technology company founded by a former Bridgewater team that combines artificial intelligence and financial expertise to deliver a full‑stack platform for investment insights and personalized financial advice. Its proprietary Economic Insights Engine powers a suite of fintech solutions accessed through an API and tailored insights. The flagship product, PortfolioPilot.com, serves individual investors as a personal AI financial advisor and manages more than $30 billion in assets. The platform also offers guided procedures, APIs, and customized analytics that help policymakers, corporations, and investors understand economic shifts and build and manage investment portfolios.

Clio is a web-based practice management system designed for solo practitioners and small law firms. It offers tools for client collaboration, case tracking, billing, and communication.

Magenta Medical is a private medical device company based in Kadima, Israel, founded in 2012. It develops catheter-based therapies for acute decompensated heart failure, including a self-expanding heart pump and temporary venous catheter-based treatments designed to relieve renal venous congestion. The technology enables quicker and safer removal of excess fluid and salt while protecting renal function, addressing a core pathophysiological element of acute heart failure and related conditions.

Cardurion Pharmaceuticals, LLC, established in 2017 and headquartered in Boston, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for heart failure and other cardiovascular diseases. The company is advancing clinical programs that target PDE9 and CaMKII inhibition, utilizing its expertise in cardiovascular signaling pathways to address significant unmet patient needs.

Amber Therapeutics specializes in developing advanced bioelectronic therapies that can sense and adapt, aiming to enhance clinical outcomes for patients with functional disorders of the peripheral nervous system.

Twelve Labs offers a platform that empowers businesses and developers to analyze and interpret video content through multiple modalities like visual and auditory data. This enables the creation of intelligent video applications across industries such as technology, media, entertainment, and security.

Faircado operates a sustainable shopping platform designed to enhance the circularity of produced goods by promoting second-hand purchases. The platform utilizes a smart algorithm that aggregates offers from various pre-owned marketplaces, allowing users to compare prices and sustainability scores of second-hand items across categories such as electronics and books. By centralizing these alternatives, Faircado enables consumers to make informed decisions that save time and money while supporting environmentally friendly shopping practices. The platform aims to reduce waste and foster a more sustainable approach to consumerism.

In-House Health is an AI-powered technical platform for modern nursing teams.

Zenas BioPharma is a clinical-stage biopharmaceutical company headquartered in Florida, USA, that specializes in developing immune-based therapies for patients. The company’s lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to target both CD19 and FcγRIIb, which are found in B cell lineages. This innovative approach aims to inhibit the activity of cells involved in various autoimmune diseases while preserving their presence, thus avoiding depletion. Through its focus on these advanced therapies, Zenas BioPharma seeks to address unmet medical needs in the treatment of autoimmune conditions.

SafeBase, Inc. is a San Francisco-based company founded in 2020 that specializes in cloud-based security software aimed at helping organizations establish and enhance their security programs. The company’s offerings include a smart trust center platform that facilitates the sharing of security posture and automates access to sensitive documents. SafeBase provides solutions such as SafeBase Inspected, which features a website badge linking to a custom security status page, as well as custom security checklists and continuous monitoring of security systems. Additionally, the software assists organizations in configuring security policies, thereby enabling them to implement robust security practices effectively.

Beehiiv operates an email newsletter platform designed for creators. It facilitates the production, monetization, and expansion of newsletters while enhancing audience engagement and growth. The platform's direct engagement model reduces reliance on cookie-based data.

ARRIS specializes in developing additive molding technology for manufacturing large-scale 3D-aligned continuous fiber thermoplastic composite parts. Its innovative process combines aligned fibers, electronics, and metallic components within topology-optimized structures, serving industries such as aerospace, automotive, and consumer products.

Xaira Therapeutics is a biotechnology company that leverages artificial intelligence to revolutionize drug discovery and development. Headquartered in the San Francisco Bay Area, Xaira brings together machine learning experts, expansive data generation, and robust therapeutic product development to advance treatments for various diseases.

Perplexity is an AI-driven search engine platform that combines large language models with traditional search engines. It uses natural language processing (NLP) and generative AI to provide conversational responses, bridging the gap between conventional search engines and interactive AI assistance.

Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.

AI Squared helps large organizations bring AI to where work happens. We do this by leveraging our SaaS or on-prem platform which combines data sources with advanced AL/ML functionality and embeds intelligent insights into critical business applications. Trusted by the largest financial institutions, the most complicated supply chain logistics companies, and the US Department of Defense, we enable seamless collaboration between data science teams and business users, driving faster, more informed decision-making.

Avenzo Therapeutics focuses on developing innovative cancer treatments. It operates a clinical-stage platform dedicated to creating novel therapies for underserved cancers, with a pipeline targeting rare and genomically defined cancers.

Foundry is a public cloud supported by an orchestration platform designed to simplify the utilization of AI computing resources. Foundry addresses fundamental economic and technical obstacles encountered in AI and deep learning. Current challenges faced by businesses, such as the notable GPU scarcity and inefficient use of computing capabilities, hinder their effective utilization of resources. Foundry employs pioneering approaches to overcome these hurdles, offering scalable GPU instances with unparalleled price-performance ratios.

Wonder is a technology company that develops an all-in-one gaming platform for Android mobile devices. The platform enables users to play, stream, and share games across devices seamlessly.

Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.

Together is a technology services platform that offers a decentralized cloud specifically for artificial intelligence development. The company focuses on constructing open-source generative AI models and infrastructure, providing tools and resources that enable developers and researchers to train, refine, and deploy these models efficiently. Together's platform emphasizes accessibility and user-friendliness, allowing organizations of various sizes to leverage and enhance AI capabilities. By contributing innovative open-source research, models, and datasets, Together plays a significant role in advancing the field of AI and fostering collaborative development efforts.

Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of microRNA-targeted therapies for various diseases. Founded in 2007 and headquartered in San Diego, California, the company focuses on innovative treatments for conditions such as kidney diseases and viral infections. Its lead product candidates include RG-012, an anti-miR targeting miR-21, currently in Phase II clinical trials for Alport syndrome, and RGLS4326, an anti-miR targeting miR-17, which is undergoing Phase Ib clinical trials for autosomal dominant polycystic kidney disease. Additionally, Regulus is advancing a pipeline of preclinical drug candidates, including RGLS5579 to inhibit miR-10b, as well as programs aimed at treating Hepatitis B virus and Non-Alcoholic Steatohepatitis. The company's work leverages the recent scientific advancements in microRNA research, which play a crucial role in regulating gene expression.

Propense.ai is a SaaS platform that utilizes AI technology to help businesses identify new revenue streams. By employing a predictive sales intelligence model, it analyzes historical and market data to uncover hidden revenue opportunities. The platform offers real-time access to cross-selling scores, precise forecasting metrics, and predictive growth intelligence, which empowers firms to understand what products or services to sell to their clients next. By surfacing high-potential market opportunities and addressing revenue leakage, Propense.ai enables business leadership and professionals to enhance client service, gain strategic insights, and ultimately increase overall revenue.

Glacier develops AI-enabled recycling robots for recycling facilities. Founded in 2019 and headquartered in San Francisco, California, the company creates affordable, high-performing, and space-efficient robots that automate the sorting of recyclable materials. Its platform combines artificial intelligence-powered sensors and robotics to streamline operations, improve sorting accuracy, and increase profitability for waste facilities.

Inkitt operates an online community for writers and readers, offering a platform where authors can share and refine their work while gaining insights from readers. The company uses data-driven approaches to identify popular stories and publishes them across various media, aiming to create blockbuster franchises similar to Disney's model.

Genmo is a technology company that develops an artificial intelligence platform for creative content generation. Its platform enables users to create high-quality videos, images, and 3D models using intuitive text and image prompts, leveraging advanced natural language processing technology. This allows video creators to generate custom visual media and produce cinematic video content with the assistance of AI.

Metronome provides billing infrastructure for software companies, facilitating rapid deployment, flexibility, and user-friendly solutions. It enables business and product teams to manage revenue and pricing independently, streamlining workflows and offering customers real-time spending insights.

Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. Its mission is to provide safe, effective, evidence-based, and affordable therapies for treating life-threatening complications of pregnancy.

Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.

Perplexity is an AI-driven search engine platform that combines large language models with traditional search engines. It uses natural language processing (NLP) and generative AI to provide conversational responses, bridging the gap between conventional search engines and interactive AI assistance.

VAST Data, Inc. is a technology company that specializes in developing innovative data storage solutions. Headquartered in New York, with additional offices in San Jose, California, the company offers a universal storage platform that utilizes Intel’s Optane SSDs as a cache for data stored on quad-level cell (QLC) SSDs. VAST Data's solutions cater to various sectors, including animation and visual effects, deep learning, life sciences, media and broadcasting, and enterprise backup and recovery. The platform is designed to enhance productivity, streamline data management, and accelerate time-to-insight for workload-intensive applications, making it particularly valuable for AI-driven organizations. Founded in 2016, VAST Data has rapidly established itself as a leading player in the data infrastructure market.

Gravel is a technology company that simplifies the process of finding qualified and trustworthy construction workers.

Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.

Martian delivers an LLM routing platform that automatically routes prompts to the most suitable language model. It employs a model mapping method to convert indecipherable matrices into human readable programs, enabling organizations to improve product performance, reduce costs, and deploy an AI model capable of handling any prompt.

Ozone is an innovative company that has developed an AI-powered video editing platform designed to enhance the creative process for users. By enabling remote collaboration, Ozone allows creative producers to edit high-definition footage seamlessly without the need for bulky hardware or slow processing times. The platform supports features such as instant video mockup creation, effortless color correction, and real-time previews of edits, making it a valuable tool for those in the creative industry. Ozone's focus is on providing a user-friendly experience that empowers creatives to extend their capabilities and streamline their workflows, all within a cloud-based environment that prioritizes speed and accessibility.

LXA is a fintech venture focused on reimagining Asia's mortgage ecosystem. Geared towards matching institutional capital pools and residential mortgage borrowers, this platform aims to utilize end-to-end technology to streamline the entire mortgage lifecycle, from loan origination and borrower processing to loan servicing. LXA was founded in early 2023 by seasoned executives across the asset management, insurance, mortgage, and technology industries to bridge the gap between mortgage assets and institutional capital in Asia, beginning with Singapore. Combining best practices from North American and European markets with a proprietary technology platform focused on digital credit decisioning and intelligent workflow orchestration, LXA provides the first of its kind solution to address strong demand from Asian insurers and borrowers for differentiated mortgage products.

Transfix, Inc. is a trucking brokerage firm based in New York, specializing in connecting shippers with carriers for freight transportation across the United States. Founded in 2010, the company has developed an advanced online freight management platform that utilizes AI-driven algorithms to optimize freight matching and enhance supply chain visibility. Transfix offers real-time shipment tracking, alerts, and insights on carrier performance, ensuring efficient and reliable transportation solutions. The company serves a diverse range of industries, including retail, food, beverage, and manufacturing, focusing on creating a sustainable freight ecosystem while minimizing empty miles and improving operational efficiency. Through its Intelligent Freight Platform, Transfix aims to revolutionize supply chain performance and support organizations in achieving their logistics goals.

Waymark is a company focused on enhancing the accessibility and quality of healthcare for individuals who receive Medicaid. It offers community-based healthcare services aimed at improving patient outcomes. The company provides health plans, insulin education, training, and employment opportunities for community-based care teams. Additionally, Waymark partners with primary care providers to help Medicaid beneficiaries manage their health effectively.

Founded in 2015, Mojo Vision specializes in developing and commercializing advanced micro-LED display technology for various applications. The company is renowned for creating the world's smallest dynamic display for augmented reality smart contact lenses. Headquartered in Saratoga, California, Mojo Vision aims to disrupt the $160 billion display industry with its proprietary quantum-dot technology.

Pair Eyewear, Inc. is a New York-based company that specializes in customizable eyeglasses for children. Founded in 2017 by Nathan Kondamuri and Sophia Edelstein, the company offers a unique approach to eyewear by providing base frames and interchangeable top frames that allow kids to express their personal style and interests. By combining functionality with creativity, Pair Eyewear transforms glasses from mere medical devices into a fun and engaging accessory for children. The company's direct-to-consumer model leverages an e-commerce platform, making the purchasing process convenient for parents while enhancing the overall experience for young wearers. Pair Eyewear is committed to offering quality, affordable glasses that are both stylish and practical, featuring hand-polished frames and shatterproof polycarbonate lenses.

Founded in 2017, Pulumi Corporation operates an infrastructure-as-code platform for developing cloud software. It offers Pulumi SDK, an open-source tool enabling developers to create, deploy, and manage cloud applications and infrastructure using code. The company also provides a web console for collaborative delivery and management of cloud apps and infrastructure across public, private, or hybrid environments.

Meeno is a technology company specializing in an AI-driven relationship mentoring app tailored for young adults, particularly Generation Z. It offers personalized coaching exercises and guidance to help users strengthen their close relationships and improve overall well-being.

Rocket.Chat Holdings, Ltd., established in 2015, specializes in developing and operating an open-source web chat platform. The company offers a comprehensive suite of features, including video conferencing, helpdesk chat, file sharing, and screen sharing, along with API and native mobile applications. Rocket.Chat also provides white labeling, integrations, and hosting services. With over 500,000 servers installed and 12 million users worldwide, the platform facilitates internal and external communication within a secure environment. Users can run Rocket.Chat on-premises or on the cloud, tailoring the platform with features like individual and group communication, video conferencing, and integration with various external communications platforms. The company's long-term vision is to replace email with a real-time, federated communications platform and foster a marketplace for app-building and services.

Modyfi is an innovative image editing platform that enhances creativity and collaboration in the design process. Utilizing artificial intelligence, Modyfi offers real-time, multi-user editing tools that facilitate seamless collaboration among designers. The platform centralizes projects and resources, allowing users to share progress, gather feedback, and engage in commenting and markups. Additionally, Modyfi incorporates video chat features, making it easier for teams to communicate effectively during the photo-editing process. By streamlining workflows, Modyfi empowers users to integrate image editing into their projects more efficiently.

Fizz is an authorized platform designed to enhance community social structures, particularly within institutions. It develops online social media software that facilitates communication and the sharing of ideas, events, and experiences among users. The platform allows individuals to post secret confessions and ask questions within a closed community, promoting social interaction while maintaining anonymity. By leveraging these features, Fizz aims to foster a more connected and engaged community environment.

NeueHealth is a healthcare company dedicated to providing high-quality, coordinated care to aging and underserved populations. It operates through two segments: NeueCare, which manages risk in partnership with external payors, serving diverse patient populations; and NeueSolutions, offering technology, services, and clinical care solutions to empower providers.

Functional Finance is a fintech platform designed to enhance the operational efficiency of the insurance industry. The company provides a comprehensive software solution that enables insurance operators to manage various aspects of money transfer, including billing, invoicing, payment collection, statement generation, and real-time automatic reconciliation for every invoice and policy. This platform allows insurance companies to unify and automate their financial operations and workflows without needing to replace their existing infrastructure.

Nexo Therapeutics is a small molecule oncology company focused on discovering and developing innovative drugs for cancer patients who have limited therapeutic options. The company utilizes a unique platform that integrates covalent ligand discovery and chemical biology, allowing it to advance small-molecule therapies aimed at challenging and previously intractable cancer targets. By unlocking a pipeline of novel oncology treatments, Nexo Therapeutics seeks to provide medical professionals with new and effective options to improve patient outcomes in the fight against cancer.

Gossamer Bio is a clinical-stage biopharmaceutical company based in San Diego that specializes in the discovery, development, and commercialization of innovative therapeutic products targeting significant unmet medical needs. Founded by former executives from Receptos, the company focuses on areas such as immunology, inflammation, fibrosis, and oncology. Its pipeline includes several promising candidates: Seralutinib, aimed at addressing pulmonary arterial hypertension; GB004, for inflammatory bowel disease; GB1275, targeting various oncology indications; and GB001, designed for moderate-to-severe eosinophilic asthma. Gossamer Bio's strategy involves leveraging a rich in-licensing environment to enhance its therapeutic offerings, supported by a team recognized for their successful track record in drug development.

Embrace is a developer of a unified observability and error monitoring platform that enables engineers to effectively manage the complexities of mobile applications. The platform provides comprehensive insights by allowing users to access detailed behavioral and technical context, helping teams identify and prioritize issues instantly. Embrace empowers engineers to track user sessions, monitor activities, and analyze data related to app performance, including every view, tap, network request, and memory usage. By eliminating fragmented solutions and guesswork, Embrace enhances the ability of companies to resolve issues quickly and optimize mobile experiences, ultimately fostering the development of better and more impactful mobile applications.

Spyglass Pharma specializes in developing innovative treatments for chronic eye diseases using advanced technologies. The company aims to deliver multiple drugs to address additional ophthalmic indications.

Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands, established in 2011 as a spin-out from Philips Healthcare. The company focuses on developing innovative in vivo chemistry to enhance the effectiveness of cancer therapies and to facilitate novel companion diagnostics. Operating from the Radboud University Medical Center in Nijmegen, Tagworks specializes in antibody-based imaging and therapy technologies. Its proprietary approach allows for the selective chemical manipulation of tagged antibodies in vivo, which improves the efficacy of established methods like radioimmuno-imaging and antibody-drug conjugates. This technology enables medical professionals to conduct imaging with significantly reduced radiation exposure for patients.

Djust provides a cloud‑based B2B platform that accelerates the launch of e‑commerce and e‑procurement solutions. The integrated product combines digital showrooms, an online marketplace, and customer relationship management tools, enabling businesses to build, upgrade, and expand their online operations efficiently.

Granica is a company that specializes in enhancing the efficiency and safety of artificial intelligence applications through its AI Data Readiness Platform. This platform assists data engineers and leaders in creating AI-ready data, which is crucial for optimizing machine learning models and analytics. By improving the efficiency of tabular and natural language processing training data, Granica significantly reduces storage costs and enhances query performance. The company focuses on mitigating risks associated with sensitive data leakage and harmful content, thereby ensuring privacy and safety in AI inputs and outputs. Granica curates and refines training datasets to select impactful samples, ultimately boosting the performance and reliability of AI models. Targeting enterprises in data-intensive sectors such as financial services, retail, geo-spatial intelligence, and autonomous vehicles, Granica enables clients to leverage AI more effectively, enhancing trust and improving business outcomes.

Instabase, Inc. is a technology company based in San Francisco, California, founded in 2015. It specializes in developing a platform that automates document processing workflows and analyzes unstructured data. The platform integrates various capabilities, including optical character recognition, data classification and extraction, and natural language processing, allowing organizations across sectors such as insurance, finance, and healthcare to streamline operations and improve decision-making. Additionally, Instabase provides a developer kit that enables the creation of customized business applications, helping institutions embed artificial intelligence into their systems and processes. Through its innovative solutions, Instabase aims to address significant business challenges and facilitate transformational outcomes for its clients.

Strive Health, LLC is a company focused on providing comprehensive solutions for chronic kidney disease. Founded in 2018 and based in Denver, Colorado, Strive Health operates dialysis centers and employs advanced predictive analytics to enhance patient care. The company offers a high-touch, technology-enabled clinical model that supports patients throughout their healthcare journey, from primary care engagement to dialysis treatment. By utilizing comparative and predictive data, Strive Health aims to identify at-risk patients and transform the management of kidney disease, promoting earlier intervention and increasing the adoption of home dialysis. This innovative approach not only improves patient outcomes but also seeks to reduce inpatient utilization, ultimately enhancing the overall experience for individuals dealing with chronic kidney conditions.

Founded in 2022, Sundeck is a Santa Clara-based company specializing in data infrastructure and analytics. It offers a platform that customizes Snowflake's behavior for every query, providing features such as warehouse optimization, adaptive controls, cost management, and new query syntax.

Union.ai is a Kubernetes-native workflow orchestration platform for data and machine learning at scale. Union.ai provides software users with the tools they need to move their ideas from concept to high-quality production. Union's aim is to organize the numerous processes required to train and grow the most sophisticated and dynamic machine learning and data products.